BRI Vaccine Partnership: The Local Production of Chinese Vaccines and the Future Network of Providing mRNA Vaccines

35 Pages Posted: 20 Jun 2022 Last revised: 23 Jun 2022

See all articles by Henry Tillman

Henry Tillman

Grisons Peak

Jie Zheng

Shanghai University of Finance and Economics

Yang Jian

Shanghai Institutes for International Studies

Date Written: May 31, 2022

Abstract

In this report, we will continue to study the impact of global health governance on curbing Covid-19 and trace the vaccine development, especially with regard to the Belt and Road Vaccine Partnership launched by China. The second section synthesizes the current progress of the world in combatting Covid-19. Due to mutations of Covid-19 variants (Delta and Omicron) and disparate vaccination rate among different countries, the third section will summarize challenges to global health governance. The fourth section will make proposals on how to close the vaccine gaps by boosting vaccines supplies and coordinating national policies on the re-opening time schedule.

Note:
Funding Information: None.

Conflict of Interests: None.

Keywords: BRI Vaccine Partnership; Global Health Governance

Suggested Citation

Tillman, Henry and Zheng, Jie and Jian, Yang, BRI Vaccine Partnership: The Local Production of Chinese Vaccines and the Future Network of Providing mRNA Vaccines (May 31, 2022). Available at SSRN: https://ssrn.com/abstract=4126972 or http://dx.doi.org/10.2139/ssrn.4126972

Henry Tillman (Contact Author)

Grisons Peak

Candlewick House,120 Cannon Street
London, EC4N 6AS
United Kingdom

Jie Zheng

Shanghai University of Finance and Economics ( email )

777 Guoding Road
Shanghai, AK Shanghai 200433
China

Yang Jian

Shanghai Institutes for International Studies

China

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Downloads
24
Abstract Views
116
PlumX Metrics